FLUOCINONIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluocinonide, and when can generic versions of Fluocinonide launch?
Fluocinonide is a drug marketed by Amneal, Cosette, Encube, Fougera Pharms Inc, Glenmark Pharms Ltd, Padagis Israel, Pai Holdings Pharm, Perrigo New York, Taro, Teva, Zydus Lifesciences, Alvogen, Padagis Us, Chartwell Rx, Fougera Pharms, Xiromed, Encube Ethicals, Macleods Pharms Ltd, Novel Labs Inc, Teva Pharms, and Zydus Pharms. and is included in forty-four NDAs.
The generic ingredient in FLUOCINONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluocinonide
A generic version of FLUOCINONIDE was approved as fluocinolone acetonide by TARO on April 27th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUOCINONIDE?
- What are the global sales for FLUOCINONIDE?
- What is Average Wholesale Price for FLUOCINONIDE?
Summary for FLUOCINONIDE
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 44 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 9 |
| Drug Prices: | Drug price information for FLUOCINONIDE |
| Drug Sales Revenues: | Drug sales revenues for FLUOCINONIDE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FLUOCINONIDE |
| What excipients (inactive ingredients) are in FLUOCINONIDE? | FLUOCINONIDE excipients list |
| DailyMed Link: | FLUOCINONIDE at DailyMed |
See drug prices for FLUOCINONIDE
Recent Clinical Trials for FLUOCINONIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Catania | N/A |
| Rochester General Hospital | N/A |
| Bausch Health Americas, Inc. | N/A |
Pharmacology for FLUOCINONIDE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for FLUOCINONIDE
Anatomical Therapeutic Chemical (ATC) Classes for FLUOCINONIDE
Paragraph IV (Patent) Challenges for FLUOCINONIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| VANOS | Cream | fluocinonide | 0.1% | 021758 | 1 | 2008-01-31 |
US Patents and Regulatory Information for FLUOCINONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosette | FLUOCINONIDE EMULSIFIED BASE | fluocinonide | CREAM;TOPICAL | 074204-001 | Jun 13, 1995 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novel Labs Inc | FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 206003-001 | Jul 21, 2017 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cosette | FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 071535-001 | Dec 2, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
